Alexandria New Medical Center (EGX:AMES)
Egypt · Delayed Price · Currency is EGP 51.90
+0.80 (1.57%)
At close: Nov 12, 2026
EGX:AMES Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12,694 | 6,866 | 2,301 | 916 | 1,145 | 849 | |
Market Cap Growth | 80.56% | 198.38% | 151.29% | -20.00% | 34.76% | 46.44% |
Enterprise Value | 12,671 | 6,858 | 2,267 | 880 | 1,115 | 819 |
Last Close Price | 51.90 | 28.50 | 9.55 | 3.80 | 4.75 | 3.49 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 120.60 | 124.73 | 77.17 | 154.36 | - | 31.95 |
PS Ratio | 25.76 | 14.67 | 6.52 | 3.30 | 4.39 | 3.09 |
PB Ratio | 42.77 | 24.87 | 10.41 | 4.79 | 6.18 | 3.52 |
P/TBV Ratio | 42.77 | 24.87 | 10.41 | 4.79 | 6.18 | 3.52 |
P/FCF Ratio | 90987.70 | 11917.45 | - | - | - | 20.88 |
P/OCF Ratio | 700.16 | 325.56 | 86.80 | - | - | 15.60 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 25.71 | 14.66 | 6.42 | 3.17 | 4.27 | 2.98 |
EV/EBITDA Ratio | 150.10 | 83.34 | 51.82 | 44.74 | 53.59 | 11.33 |
EV/EBIT Ratio | 192.18 | 100.71 | 69.27 | 92.27 | 105.46 | 17.36 |
EV/FCF Ratio | 90825.60 | 11904.89 | - | - | - | 20.13 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.07 | 0.06 | 0.16 | - | 0.04 | 0.08 |
Debt / EBITDA Ratio | 0.25 | 0.19 | 0.80 | - | 0.31 | 0.25 |
Debt / FCF Ratio | 149.79 | 26.94 | - | - | - | 0.45 |
Net Debt / Equity Ratio | -0.08 | -0.09 | 0.00 | -0.22 | -0.25 | -0.20 |
Net Debt / EBITDA Ratio | -0.27 | -0.31 | 0.01 | -2.11 | -2.26 | -0.66 |
Net Debt / FCF Ratio | -162.10 | -44.39 | -0.03 | 2.77 | 6.36 | -1.18 |
Asset Turnover | 1.15 | 1.18 | 1.07 | 0.96 | 0.83 | 0.83 |
Inventory Turnover | 22.66 | 24.56 | 22.89 | 25.42 | 22.23 | 20.18 |
Quick Ratio | 1.54 | 1.43 | 1.11 | 1.34 | 1.37 | 1.90 |
Current Ratio | 1.66 | 1.55 | 1.23 | 1.49 | 1.50 | 2.06 |
Return on Equity (ROE) | 19.86% | 22.15% | 14.47% | 3.15% | -0.33% | 12.24% |
Return on Assets (ROA) | 9.63% | 10.73% | 6.17% | 2.06% | 2.11% | 8.94% |
Return on Invested Capital (ROIC) | 18.99% | 21.64% | 12.52% | 2.80% | -0.30% | 14.40% |
Return on Capital Employed (ROCE) | 21.30% | 23.70% | 14.10% | 4.80% | 5.60% | 19.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.83% | 0.80% | 1.30% | 0.65% | -0.06% | 3.36% |
FCF Yield | 0.00% | 0.01% | -0.61% | -1.64% | -0.65% | 4.79% |
Dividend Yield | 0.19% | - | - | - | - | 1.47% |
Payout Ratio | - | - | - | - | - | 6.00% |
Total Shareholder Return | 0.19% | - | - | - | - | 1.47% |